Alkagesta’s finance team participated in TFG Geneva 2026, a commodity trade finance conference whose agenda ranged from funding physical cargoes to managing disruption in global trade. According to Alkagesta Media, the company used the gathering to engage with banks, insurers and other liquidity providers supporting its trading activities in petroleum products, biofuels, fertilisers and steel.
Organised by Trade Finance Global at the InterContinental Genève during Geneva Commodities Week, the event attracted more than 500 professionals, the company’s report said. Participants came from trading houses, trade and commodity finance banks, credit and political risk insurers, and compliance, legal and logistics businesses. The programme comprised nine panel discussions featuring more than 40 speakers, bringing together both financing institutions and providers of services to commodity traders.
Opening discussions focused on the outlook for commodity trading against a backdrop of volatile markets and persistent supply chain disruption. The programme examined practical responses and lessons from the preceding year’s changes in trade flows. Separate sessions considered ways to attract additional liquidity into commodity trade finance and explored inventory financing, including the structures banks and alternative lenders use to fund physical cargoes and goods held in storage.
Energy transition financing was another theme, with a panel examining how commodity trade finance banks are adapting to sustainable fuels and lower-carbon supply chains. Later sessions addressed insurance in the context of conflict, the forces shaping the critical minerals agenda and the potential role of digital asset lending as an investment avenue for trade finance.
Alkagesta Media said the company trades across approximately 48 countries and presented its attendance as a continuation of its Banking Partners Summit in Malta in October. It linked the Geneva engagement to strengthening financing relationships that it said supported record growth through 2026, without providing growth figures in the report.
Read the original announcement on Alkagesta.